[Therapeutic effect and effect on the pituitary adrenal functions of fluocortine-butylester in eczema during childhood (author's transl)].
A new topical corticosteroid: fluocortin-butylester, was employed in 11 eczematous children (atopic and seborrhoeic dermatitis), with a good clinical result. These topical applications involve no significant risk of interference with the pituitary-adrenal function.